Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

23. Juli 2020 08:30 ET | Quelle: Biofrontera AG

Supervisory Board of Biofrontera AG renews Management Board appointment

Leverkusen, Germany, July 23, 2020 (GLOBE NEWSWIRE) -- The Supervisory Board of Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, today...
27. August 2019 02:15 ET | Quelle: Biofrontera AG

Biofrontera shows robust growth during first six months of 2019

Leverkusen, Germany, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its...
05. August 2019 09:00 ET | Quelle: Biofrontera AG

Biofrontera provides update on Cutanea integration

Leverkusen, Germany, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (“Biofrontera” or the “Company”), an international biopharmaceutical company,...
08. Januar 2019 02:02 ET | Quelle: Biofrontera AG

Biofrontera receives FDA approval for upscaling of batch size for Ameluz® production

Leverkusen, Germany, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced that...
26. November 2018 13:08 ET | Quelle: Biofrontera AG

Biofrontera to Participate in Two Upcoming Investor Conferences

Leverkusen, Germany, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced its...
17. September 2018 05:17 ET | Quelle: Biofrontera AG

Biofrontera uses the long summer months to introduce daylight photodynamic therapy (PDT) with Ameluz® in the EU

Leverkusen, Germany, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, today announced an update on...
03. September 2018 05:35 ET | Quelle: Biofrontera AG

Correction of news release from August 31, 2018: Biofrontera reports significant revenue growth for the first 6 months of 2018

Leverkusen, Germany, Sept. 03, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported...